Copyright
©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers
Ye-Wei Liu, Frederik De Keyzer, Yuan-Bo Feng, Feng Chen, Shao-Li Song, Johan Swinnen, Guy Bormans, Raymond Oyen, Gang Huang, Yi-Cheng Ni
Ye-Wei Liu, Gang Huang, Shanghai Key Laboratory for Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China
Ye-Wei Liu, Frederik De Keyzer, Yuan-Bo Feng, Feng Chen, Johan Swinnen, Guy Bormans, Raymond Oyen, Yi-Cheng Ni, Biomedical Group, Campus Gasthuisberg, KU Leuven, Leuven 3000, Belgium
Ye-Wei Liu, Shao-Li Song, Gang Huang, Institute of Clinical Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
Ye-Wei Liu, Gang Huang, Institute of Health Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) & Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), Shanghai 200025, China
Author contributions: Ni YC, Liu YW, Huang G, Swinnen J, Bormans G and Oyen R designed the research; Liu YW, Feng YB, Chen F and Ni YC performed the research; Liu YW, De Keyzer F and Chen F analyzed the data; Liu YW, Ni YC and Song SL prepared the manuscript; Ni YC, Swinnen J, Bormans G and Oyen R reviewed the manuscript; all authors approved the final version for publication.
Institutional review board statement: This study was reviewed and approved by the ethics committee of KU Leuven.
Institutional animal care and use committee statement: This animal experiment was performed in compliance with European and national regulations after approval by KU Leuven university ethics committee (P147/2013) for animal care and use.
Conflict-of-interest statement: The authors declare no potential conflicts of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Yi-Cheng Ni, MD, PhD, Full Professor, Theragnostic Laboratory, Department of Imaging and Pathology, Biomedical Group, KU Leuven, Herestraat 49, Leuven 3000, Belgium.
yicheng.ni@kuleuven.be
Telephone: +32-16-330165 Fax: +32-16-343765
Received: March 5, 2018
Peer-review started: March 6, 2018
First decision: March 14, 2018
Revised: April 1, 2018
Accepted: April 9, 2018
Article in press: April 9, 2018
Published online: July 7, 2018
Processing time: 121 Days and 11.6 Hours
